•
Insights
Where finance sits in the treatment conversation
Finance is not a payment method, it shapes the decision
In most dental practices, finance is positioned as a payment mechanism introduced after the treatment plan is presented. This framing assumes the patient has already decided to proceed and only needs help paying.
In practice, this is not how decisions are made. For higher-value treatments, the way payment is presented directly influences whether the patient proceeds at all.
The traditional model: finance is introduced too late
In many practices, the treatment conversation follows a linear structure:
Treatment is explained
Full price is presented, for example £3,000
Hesitation emerges
Finance is introduced as an option
This sequence creates a structural limitation. By leading with a large, upfront price, patients naturally anchor on affordability and perceived financial burden. Finance is then introduced as a way to reduce that burden.
At this point, finance is no longer shaping the decision. It is attempting to recover it. The conversation has already moved into hesitation.
A more effective model: parallel positioning
Higher-performing practices take a different approach. They present price and payment options together.
This reframes the decision from "Can I afford £3,000?" to "How would I prefer to pay?". The shift reduces initial resistance, normalises instalments, and keeps the decision active. Finance becomes part of the decision, not a response to it.
The marketing-led model: finance before the visit
The most advanced practices extend this approach further, positioning finance before the patient even enters the practice. This is particularly common among high-volume Invisalign providers, specialist clinics, and growth-focused businesses.
Instead of leading with total price, they lead with monthly affordability, for example "Invisalign from £100 per month". This changes patient behaviour upstream: patients self-select based on affordability, barriers are lowered before consultation, and demand increases. Finance becomes a mechanism to bring patients into the practice, not just convert them once they arrive.
Pre-qualification and demand shaping
Some practices go further by introducing finance early in the journey, or enabling patients to explore eligibility before consultation. This serves two purposes.
First, it improves efficiency by reducing time spent on non-viable cases and aligning expectations early. Second, it improves conversion quality, because patients arrive more prepared and more confident in proceeding.
The role of price confidence
The ability to position finance early depends on one key factor: confidence in pricing.
When pricing is clear, practices can communicate early, anchor expectations, and present finance confidently. When pricing is uncertain, finance is delayed. This is common in treatments requiring post-consultation planning or variable clinical pathways.
Delays in pricing lead to delayed decisions, reduced momentum, and lower conversion. The earlier a price can be confidently established, the earlier finance can shape the decision.
Simplicity drives decisions
Patients do not need full technical detail or complex breakdowns. They need clarity on outcome and clarity on cost.
Complexity reduces conversion. This includes multiple treatment variants, multiple finance options, and inconsistent presentation. High-performing practices instead standardise treatment positioning, define clear pricing ranges, and offer a small set of finance options. This enables faster decisions, clearer conversations, and higher conversion rates.
What open days reveal
One of the clearest examples of effective finance positioning comes from Invisalign and implant open days. During these events, the entire team is aligned, the objective is clear, and processes are tightly defined.
Pricing is clear and committed, finance is consistently presented, and messaging is aligned across marketing and consultation. Finance is treated as a standard part of the offer, not an optional add-on. The result is higher case acceptance, faster decision-making, and increased utilisation of finance.
This performance is not driven by different patients or different treatments. It is driven by focus and execution discipline. Most practices can achieve this level of performance temporarily. The difficulty is maintaining it consistently in day-to-day operations. Open days do not introduce a new model. They reveal what is already possible.
Demand is not the constraint
Patient behaviour consistently supports early and clear finance positioning. Research from Tabeo in 2017 shows that around 70% of patients prefer 0% finance over debit or credit card payments for treatments above £1,000.
This is reflected in real-world performance: SmileDirectClub at around 70% finance utilisation, leading Invisalign providers at 40 to 60% or more, and specialist practices with consistently high adoption. When finance is presented clearly, it becomes the preferred option for a large share of patients.
What patients actually optimise for
Patients are not primarily optimising for APR. They are optimising for affordability, cash flow, and the ability to proceed immediately.
A treatment with a lower total cost and moderate APR may be preferred over a higher-cost treatment at 0%. Price anchoring matters more than interest structure.
Finance as positioning, not fallback
The role of finance in the treatment conversation can be summarised as a shift. From late introduction, reactive recovery, and inconsistent delivery, to early positioning, proactive framing, and standardised execution.
Final takeaway
The difference between high and low-performing practices is not access to finance or patient demand. It is how and when finance is introduced in the decision process. When finance is presented early, clearly, and consistently, it shapes the decision rather than reacting to it, and becomes the default choice for a large share of patients.